The PPARδ ligand L-165041 inhibits vegf-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ

Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner

(2011) Linah Al-Alem et al.   PLoS One

A Comparison of Methods for Quantifying Angiogenesis in the Matrigel Assay In Vitro

(2011) Cheen Peen Khoo et al.   TISSUE ENGINEERING PART C-METHODS

PPAR -independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells

(2010) Y. Hu et al.   JOURNAL OF ENDOCRINOLOGY

Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions

(2009) Kay-Dietrich Wagner et al.   PHARMACOLOGY & THERAPEUTICS

PPAR-δin Vascular Pathophysiology

(2009) Nanping Wang   PPAR Research

PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle

(2008) Hyun-Joung Lim et al.   ATHEROSCLEROSIS

Mechanisms of angiogenesis

(2008) A. F. Karamysheva   BIOCHEMISTRY-MOSCOW

Peroxisome Proliferator–Activated Receptor-δ Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells Through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway

(2008) Jung-Kyu Han et al.   CIRCULATION